tiprankstipranks

Matthew Kapusta Insider Profile

11 Followers
Matthew Kapusta, SVP BD at AngioDynamics, holds 660.66K shares in uniQure (Ticker: QURE), holds 0.00 shares in Decibel Therapeutics (Ticker: DBTX), holds 30.06K shares in AngioDynamics (Ticker: ANGO).
tipranks
Matthew Kapusta

Matthew Kapusta
AngioDynamics (ANGO)
SVP BD

Ranked #77,128 out of 106,487 Corporate Insiders

Profitable Transactions

50%
9 out of 18 Profitable Transactions

Average Return

-6.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$11M
97.26%
2.74%
A breakdown of Matthew Kapusta's holdings

Insider Roles

uniQure
(QURE)
CEO, Managing Director, Director
AngioDynamics
(ANGO)
SVP BD
Roles that Matthew Kapusta holds in companies

Most Profitable Insider Trade

Stock:
uniQure
(QURE)
Rating:Informative Sell
Date:Mar 09, 2023 - Mar 09, 2024
Return:+74.30%
The most profitable trade made by Matthew Kapusta

Matthew Kapusta's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AngioDynamics
Nov 19, 2014
SVP BD
Uninformative Sell
23.46K
$303.33K
uniQure
Mar 06, 2026
CEO, Managing Director, Director
Uninformative Buy
$10.77M
DBTX
Decibel Therapeutics
Sep 25, 2023
Uninformative Sell
$0.00
List of latest transactions for each holding click on a transaction to see Matthew Kapusta's performance on stock

Matthew Kapusta insider profile FAQ

What is the percentage of profitable transactions made by Matthew Kapusta?
The percentage of profitable transactions made by Matthew Kapusta is 50%.
    What is the average return per transaction made by Matthew Kapusta?
    The average return per transaction made by Matthew Kapusta is -6.80%.
      What stocks does Matthew Kapusta hold?
      Matthew Kapusta holds: ANGO, QURE, DBTX stocks.
        What was Matthew Kapusta’s latest transaction?
        Matthew Kapusta latest transaction was an Uninformative Buy of ―.
          What was Matthew Kapusta's most profitable transaction?
          Matthew Kapusta’s most profitable transaction was an Informative Sell of QURE stock on March 9, 2023. The return on the trade was 74.30%.
            What is Matthew Kapusta's role in AngioDynamics?
            Matthew Kapusta's role in AngioDynamics is SVP BD.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.